Respiratory syncytial virus

Curr Probl Pediatr. 1993 Feb;23(2):50-79. doi: 10.1016/0045-9380(93)90003-u.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Age Factors
  • Anti-Bacterial Agents / therapeutic use
  • Antibody Formation
  • Child, Preschool
  • Humans
  • Immunity, Cellular
  • Incidence
  • Infant
  • Prevalence
  • Respiratory Syncytial Viruses*
  • Respirovirus Infections* / diagnosis
  • Respirovirus Infections* / epidemiology
  • Respirovirus Infections* / immunology
  • Respirovirus Infections* / therapy
  • Risk Factors
  • Vaccines
  • gamma-Globulins / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Anti-Bacterial Agents
  • Vaccines
  • gamma-Globulins